Zhang F#, Yu XC#, Wu YZ, Li L*. De novo design of lipopeptides with antimicrobial potency enabled by a chain-as-prompt deep learning framework. Nature Communications 2026; doi: 10.1038/s41467-026-78763-8.
Sun RZ#, You RX#, Zhou YW, He HY, Wang WF, Qu XD, Lu YH*, Li L*. Multi‐targeting non‐specific genome engineering in bacteria. Advanced Science 2026; 13:e21532.
Li L*, Zhou YW, Wu YZ. Identification of a pair of linear or cyclic naturally inspired bifunctional lipopeptide antibiotics that overcome antimicrobial resistance. Advanced Science 2025; 12:e09796.
Li L, Koirala B, Hernandez Y, MacIntyre LW, Russo R, Ternei MA, Brady SF*. Identification of structurally diverse menaquinone-binding antibiotics with in vivo activity against multidrug-resistant pathogens. Nature Microbiology 2022; 7:120-131.
Zhang F#, Zhang F#, Yu XC#, Sun RZ, Wu YZ, Zhou YW, Li L*. Discovery of a novel family of Gram-negative-active cationic cyclolipopeptides by motif search-guided chemical synthesis. CCS Chemistry 2025; 7:2441-2450.
Sun RZ, You RX, Yu XC, Zhao D, Li L*. Discovery and synthesis of a Gram-negative-active cationic lipopeptide antibiotic inspired by primary sequences from underexplored Gram-negative bacteria. Organic Letters 2024; 26:1348-1352.
Sun RZ#, Zhao D#, Yu XC#, Zhang F, You RX, Luo XX, Li L*. Discovery of a family of menaquinone-targeting cyclic lipodepsipeptides for multidrug-resistant Gram-positive pathogens. Communications Biology 2024; 7:1453.